The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance | The Futures Summit

About this episode

The episode discusses a partnership to deliver lenacapavir for HIV prevention and its implications for U.S. foreign assistance strategy.

In September 2025, the U.S. Department of State, Gilead Sciences, and the Global Fund to Fight AIDS, Tuberculosis and Malaria announced a novel partnership to procure and deliver lenacapavir—a groundbreaking twice-yearly injectable pre-exposure prophylaxis (PrEP) for HIV prevention—to up to two million people over next three years. On Tuesday, April 14, the leadership of these three entities convened to discuss the partnership now that doses have begun to arrive in country and have been delivered. Katherine E. Bliss, Director of Immunizations and Health Systems Resilience and Senior Fellow with the CSIS Global Health Policy Center moderated the conversation with Jeremy P. Lewin, Senior Official for the Office of the Under Secretary for Foreign Assistance, Humanitarian Affairs, and Religious Freedom at the U.S. Department of State; Daniel O’Day, Chairman and CEO of Gilead Sciences; and Peter Sands, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Together they examined how this deal fits into a renewed U.S. strategy for foreign assistance focused on big bets and advancing American innovations around the world, what challenges lie on the horizon as…

People in this episode

Host: Katherine E. Bliss

Guests: Jeremy P. Lewin, Daniel O’Day, Peter Sands

Topics covered

• HIV prevention
• U.S. foreign assistance
• public health partnerships
• global health innovations
• injectable PrEP

Keywords

• lenacapavir
• HIV
• foreign assistance
• Gilead Sciences
• Global Fund
• public health
• injectable PrEP
• U.S. Department of State

Mentioned in this episode

Organizations: U.S. Department of State, Gilead Sciences, Global Fund to Fight AIDS, Tuberculosis and Malaria

Products: lenacapavir

More episodes of Take as Directed

• Dr. Jeffrey Gold, President of the University of Nebraska: “Containing outbreaks is always in our national interest.” · June 11, 2026 · 39 min
• Professor Rebecca Katz, Georgetown University: the Health Security Operations Center during the FIFA World Cup · May 21, 2026 · 31 min
• Professor Paul Spiegel, Johns Hopkins University: the release of the Lancet Commission report on health, conflict and forced displacement · May 20, 2026 · 45 min
• Priya Basu, the Pandemic Fund: "Countries are not sitting on the fence. They are lining up." · May 8, 2026 · 36 min
• A Conversation with Dr. Sania Nishtar, CEO of Gavi, the Vaccine Alliance | The Futures Summit · May 6, 2026 · 48 min
• Dr. Eli Cahan: “Human beings are wired for stories.” · May 4, 2026 · 40 min